Stock listing

Frankfurt:5J90 Fluicell AB Aktie

German listing (Frankfurt) of Fluicell AB · home listing Stockholm:FLUI

Follow Fluicell AB into a list and get an email when it puts out news.

Share price · FWB:5J90

€1.83 EUR -0.18 (-9.0%)

Close on Nov 20, 2026

Past year +136.9% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
€1.83 – €1.89 EURNov 20, 2026
Market cap
€2.51M EURAt the close on Nov 20, 2026 · price × 1.37M shares outstanding
52-week range
€0.722 – €5.27 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€79 EURMedian day 0 shares · 55 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
Fluicell AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:FLUI · Home21.10 SEK-1.90 (-8.3%)97920.8022.8020.8023.00Close on Nov 20, 2026
Frankfurt:5J90€1.83 EUR-0.18 (-9.0%)—€1.89€1.89€1.83€2.01Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:5J90 · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€2.492+0.149+6.4%€2.332€2.503€2.3160
€2.343-0.068-2.8%€2.373€2.374€2.3330
€2.411+0.083+3.6%€2.417€2.418€2.380
€2.328-0.033-1.4%€2.328€2.328€2.3280
€2.361-0.107-4.3%€2.50€2.511€2.3550
€2.468+0.025+1.0%€2.451€2.495€2.4480
€2.443+0.044+1.8%€2.443€2.443€2.4430
€2.399-0.013-0.5%€2.399€2.399€2.3990
€2.412+0.018+0.8%€2.412€2.412€2.4120
€2.394+0.063+2.7%€2.40€2.40€2.3940
€2.331-0.057-2.4%€2.331€2.331€2.3310
€2.388-0.086-3.5%€2.388€2.388€2.3880
€2.474+0.019+0.8%€2.474€2.474€2.4740
€2.455-0.053-2.1%€2.468€2.468€2.4480
€2.508+0.09+3.7%€2.508€2.508€2.5080
€2.418+0.114+4.9%€2.418€2.418€2.4180
€2.304-0.173-7.0%€2.304€2.304€2.3040
€2.477+0.158+6.8%€2.477€2.477€2.4770
€2.319-0.179-7.2%€2.397€2.405€2.3120
€2.498-0.023-0.9%€2.498€2.498€2.4980
€2.521-0.005-0.2%€2.535€2.552€2.4930
€2.526-0.037-1.4%€2.526€2.526€2.5260
€2.563+0.029+1.1%€2.586€2.596€2.5580
€2.534-0.083-3.2%€2.534€2.534€2.5340
€2.617+0.03+1.2%€2.617€2.617€2.6170
€2.587+0.042+1.7%€2.551€2.587€2.551,000
€2.545-0.046-1.8%€2.555€2.56€2.5190
€2.591+0.012+0.5%€2.591€2.591€2.5910
€2.579-0.018-0.7%€2.579€2.579€2.5790
€2.597+0.028+1.1%€2.577€2.605€2.5550
€2.569-0.04-1.5%€2.615€2.616€2.5640
€2.609+0.038+1.5%€2.609€2.609€2.6090
€2.571-0.079-3.0%€2.624€2.624€2.5570
€2.65-0.069-2.5%€2.665€2.672€2.6410
€2.719-0.012-0.4%€2.719€2.719€2.7190
€2.731-0.105-3.7%€2.731€2.731€2.7310
€2.836-0.012-0.4%€2.836€2.836€2.8360
€2.848-0.05-1.7%€2.848€2.848€2.8480
€2.898-0.025-0.9%€2.898€2.898€2.8980
€2.923+0.105+3.7%€2.923€2.923€2.9230
€2.818+0.209+8.0%€2.818€2.818€2.8180
€2.609-0.012-0.5%€2.609€2.609€2.6090
€2.621-0.061-2.3%€2.63€2.653€2.6080
€2.682-0.061-2.2%€2.682€2.682€2.6820
€2.743-0.022-0.8%€2.743€2.743€2.7430
€2.765+0.081+3.0%€2.765€2.765€2.7650
€2.684-0.009-0.3%€2.684€2.684€2.6840
€2.693+0.043+1.6%€2.693€2.693€2.6930
€2.65-0.171-6.1%€2.65€2.65€2.650
€2.821-0.358-11.3%€2.821€2.821€2.8210
€3.179+0.078+2.5%€3.179€3.179€3.1790
€3.101+0.026+0.8%€3.101€3.101€3.1010
€3.075+0.225+7.9%€3.075€3.075€3.0750
€2.85-0.078-2.7%€2.85€2.85€2.850
€2.928+0.165+6.0%€2.928€2.928€2.9280
€2.763-0.048-1.7%€2.763€2.763€2.7630
€2.811+0.301+12.0%€2.701€2.82€2.666680

Splits

1 split · FWB:5J90 · every price before a split is adjusted for it

DayRatioWhat
1-for-350Consolidation
Ticker
Frankfurt:5J90
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

Latest news

All Fluicell AB news

Fluicell AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
3 in all · newest Sep 2, 2025 · oldest 2020
Decks
1 deck · latest May 22, 2023

Where Fluicell AB is listed

ListingExchangeCountryCurrency
Stockholm:FLUI · Home listingStockholmSwedenSEK
gettex:5J90gettexGermanyEUR
Lang & Schwarz:A411NMLang & SchwarzGermanyEUR
LS Exchange:A411NMLS ExchangeGermanyEUR
Stuttgart:5J90StuttgartGermanyEUR
Frankfurt:5J90 · This pageFrankfurtGermanyEUR
Munich:5J90MunichGermanyEUR

Valuation

EV/sales 1.6× against a median of 26.9×: 3rd lowest of 5 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
30.96M SEK
P/E
10.4×
EV/sales
1.6×
EV/EBITDA
10.7×
Price/book
1.8×
Gross margin
91.6%
Operating margin
12.9%
Net margin
14.1%
Debt to equity
0.1×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Fluicell AB · OMXSTO:FLUIUS$2.83MUS$3.03M10.4×1.6×10.7×1.8×14.1%0.1×n/a
Skye Bioscience, Inc. · NASDAQ:SKYEUS$3.10M−US$1.71Mn/an/an/a2.3×n/a0.0×0.85
Creative Medical Technology Holdings, Inc. · NASDAQ:CELZUS$3.06M−US$3.79Mn/a−1,263×n/a0.4×n/a0.0×1.53
Oncology Pharma Inc. · OTC:ONPHUS$3.04Mn/an/an/an/an/an/an/a1.62
Imunon, Inc. · NASDAQ:IMNNUS$3.00MUS$5.90Mn/an/an/a1.1×n/a2.6×0.57
Gelteq Limited · NASDAQ:GELSUS$2.89MUS$6.27Mn/a57.2×n/a0.3×n/a0.4×0.83
Curis, Inc. · NASDAQ:CRISUS$2.85M−US$1.42Mn/an/an/a1.1×n/a0.3×1.85
Alligator Bioscience AB · OMXSTO:ATORXUS$2.79MUS$1.47Mn/a53.3×n/a1.2×n/a1.2×n/a
Traws Pharma, Inc. · NASDAQ:TRAWUS$2.69MUS$351,448n/an/an/an/an/an/a2.07
NextCell Pharma AB · OMXSTO:NXTCLUS$2.69MUS$626,140n/a0.6×n/a0.6×−440.8%0.0×n/a
Bioxytran, Inc. · OTC:BIXTUS$2.66MUS$2.59Mn/an/an/an/an/an/a-1.20
Median of the othersUS$2.87MUS$626,14026.9×1.1×−440.8%0.3×1.19

Team and board

Officers

OfficerRole
Carolina TrkuljaCEO
Joakim WahlbergChief Financial Officer
Gavin D. M. JeffriesCHIEF TECHNOLOGY OFFICER
Jonas HannestadCHIEF MARKETING & COMMUNICATIONS OFFICER
Vladimir KirejevSenior R&D Scientist and Laboratory Manager

Board

DirectorRole
Niklas FriskChairman of the board
Abdul KaderBoard member
Alex ScheepersBoard member
Carl FhagerBoard member
Daniel T. ChiuBoard member
Karin JennbackenBoard member
Owe OrwarBoard member
Peter KjällBoard member

Events

QuarterResultsShare move
Q1 2024May 16, 2024 · After close+1.8%
Q4 2023Jan 4, 2024 · After close+3.3%

Open Events

Decks

DeckKindSlidesDate
Investor Day (May 2023)Investor day70 slidesMay 22, 2023

Open Decks

Financials

Annual, in SEK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue6.00M1.86M3.34M3.25M2.60M4.63M2.49M1.23M1.05M2.63M
Cost of revenue14.7M1.59M1.60M663.0K715.0K988.0K443.0K391.0K8.49M7.59M
Gross profit-8.69M3.76M1.74M2.59M1.89M3.65M2.04M835.0K-7.44M-4.96M
Selling, general and administrative11.9M14.4M18.6M16.9M9.94M7.13M8.32M7.43M3.96M4.65M
Operating income-8.69M-15.8M-26.9M-21.7M-21.7M-17.0M-18.7M-14.8M-7.44M-4.97M
Depreciation and amortization370.0K440.0K610.0K720.0K588.0K605.0K522.0K326.0K71.0K85.0K
EBITDA-8.31M-15.4M-26.3M-21.0M-21.1M-16.4M-18.2M-14.5M-7.37M-4.88M
Interest expense193.0K79.0K30.0K47.0K27.0K564.0K421.0K2.00K34.0K27.0K
Income before tax-8.33M-15.5M-26.6M-21.6M-21.7M-17.6M-18.6M-14.7M-7.47M-4.95M
Income tax442.1K-120.0K27.0K564.0K398.1K-78.0K34.0K-16.0K
Net income-8.33M-15.5M-26.6M-21.5M-21.7M-18.2M-18.6M-14.7M-7.47M-4.95M
Earnings per share, basic-6.07-13.10-25.45-0.32-0.37-0.33-62.24-52.95-35.86-37.72

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents2.26M15.9M2.76M24.5M20.7M18.8M8.44M22.2M7.83M1.10M
Receivables2.20M1.38M1.24M2.79M1.93M1.77M1.67M529.0K1.44M820.0K
Inventory3.04M3.35M3.15M1.55M1.84M1.91M818.0K936.0K877.0K443.0K
Current assets7.60M20.7M7.61M29.2M24.8M22.9M11.3M24.0M10.8M2.50M
Property, plant and equipment445.0K1.14M1.54M2.30M1.84M1.60M1.83M1.49M206.0K273.0K
Total assets18.5M25.5M9.34M31.8M27.0M24.8M19.9M26.0M11.5M2.77M
Accounts payable1.30M897.0K1.50M858.0K1.05M736.0K1.87M854.0K759.0K226.0K
Current liabilities7.57M6.05M8.91M8.32M7.87M5.33M9.71M2.60M1.95M861.0K
Long-term debt0
Total debt5.00M73.0K220.0K
Total liabilities7.57M6.27M8.91M8.32M7.87M5.33M9.71M2.60M1.95M934.0K
Shareholders' equity10.9M19.2M425.0K23.4M19.1M19.5M10.2M23.4M9.58M1.84M
Shares outstanding1.37M1.18M1.04M67.7M59.2M55.1M299.4K277.6K208.3K131.2K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-4.95M-15.7M-27.2M-21.0M-18.6M-17.6M-17.1M-12.5M-7.83M-5.50M
Capital spending-4.95M-3.49M0-1.14M-772.0K-331.0K-812.0K-1.56M-500.0K-83.0K
Free cash flow-13.6M-15.7M-27.2M-22.2M-19.4M-17.9M-17.9M-14.0M-8.33M-5.58M
Cash from investing-8.67M-3.49M0-1.14M-772.0K-331.0K-812.0K-1.56M-500.0K-83.0K
Cash from financing032.3M5.53M25.9M21.3M28.3M4.09M28.4M15.1M5.93M
Dividends paid-5.00M
Share buybacks039.5M3.87M31.7M23.2M30.8M-6.40M33.7M16.4M6.10K
Change in cash-13.7M13.2M-21.7M3.76M1.89M10.4M-13.8M14.4M6.73M353.0K

Open Financials

Cap table

Built by 6ix from Fluicell AB’s releases

Common shares
1,373,703
Fully diluted
1,373,703

Fully diluted

LineShares
Common shares1,373,703

Share count over time

CountShares
Nov 22, 20261,373,703

Open Cap table

Shareholders

TradeTradeSharesPriceValueDate
Joakim Wahlberg
Chief Financial Officer (CFO)
Buy204SEK 11.00SEK 2,244Mar 13, 2026
Joakim Wahlberg
Chief Financial Officer (CFO)
Buy600SEK 11.00SEK 6,600Mar 6, 2026
Joakim Wahlberg
Chief Financial Officer (CFO)
Buy39SEK 10.91SEK 425Mar 5, 2026
Joakim Wahlberg
Chief Financial Officer (CFO)
Buy1,000SEK 10.20SEK 10,200Jan 19, 2026
Joakim Wahlberg
Chief Financial Officer (CFO)
Buy1,000SEK 10.50SEK 10,500Jan 13, 2026
Joakim Wahlberg
Chief Financial Officer (CFO)
Buy7SEK 10.20SEK 71Jan 12, 2026
Joakim Wahlberg
Chief Financial Officer (CFO)
Buy1,000SEK 10.30SEK 10,300Dec 9, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Abdul KaderBoard member · Since at least Nov 5, 2026
Alex ScheepersBoard member · Since at least Nov 4, 2026
Carl FhagerBoard member · Since at least Nov 5, 2026
Carolina TrkuljaCEO · Since at least Nov 5, 2026
Daniel T. ChiuBoard member · Since at least Nov 5, 2026
Gavin D. M. JeffriesCHIEF TECHNOLOGY OFFICER · Since at least Nov 5, 2026
Joakim WahlbergChief Financial Officer · Since at least Nov 5, 2026
Jonas HannestadCHIEF MARKETING & COMMUNICATIONS OFFICER · Since at least Nov 5, 2026
Karin JennbackenBoard member · Since at least Nov 5, 2026
Niklas FriskChairman of the board · Since at least Nov 5, 2026
All 13 people
PersonSeat
Owe OrwarBoard member · Since at least Nov 5, 2026
Peter KjällBoard member · Since at least Nov 5, 2026
Vladimir KirejevSenior R&D Scientist and Laboratory Manager · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Fluicell AB.